All news

MSD Switzerland appoints Ans Heirman as new Managing Director
01.09.2020

MSD Continues to Foster Vibrant, Creative Workspaces as it Launches New Zurich Hub
30.06.2020

Rebecca Poehnelt takes over as interim Managing Director of MSD Switzerland
11.05.2020

MSD in Switzerland launches new gender-neutral parental leave policy effective February 1st, 2020
13.02.2020

MSD Expands Operations in Switzerland
31.01.2020

Running for a good cause
27.10.2019

Human Papillomavirus (HPV): More Needs to Be Done in Terms of Information and Education
02.09.2019

Top Employer Switzerland: MSD among the top five
26.08.2019

Shingles is painful, unpredictable and can affect anyone!
08.07.2019

Dr. Ulrike Thull elected Member of the new Advance Board
18.06.2019

MSD supports awareness campaign on World IBD Day 2019
15.05.2019

WHO World Antibiotic Awareness Week, November 12-18
20.11.2018

MSD started with largest company team at the SwissCityMarathon Lucerne
05.11.2018

Jean-Blaise Defago joins MSD Switzerland as Director Policy & Communications
01.09.2018

MSD is Charity Supporting Partner at the Swiss City Marathon Lucerne
27.08.2018

Apprentices at MSD Switzerland graduated successfully
06.07.2018

MSD supports World IBD Day
15.05.2018

MSD supports national skin cancer campaign
03.05.2018

Dr. Maurice Hilleman - an exceptional figure in vaccine development
20.04.2018

MSD opens forensic laboratory at R&D site in Schachen
23.03.2018

First World HPV Day on Sunday 4 March 2018
02.03.2018

MSD main partner of Trendtage Gesundheit Luzern 2018
28.02.2018

MSD again certified as Top Employer
13.02.2018

MSD supports World Cancer Day
02.02.2018

MSD introduces PARIS, a digital risk identification tool for diabetics and cardiovascular patients in Switzerland.
13.11.2017

MSD offers apprenticeships in the Lucerne Region.
28.08.2017

Expert think tank for immuno-oncology – An initiative by MSD and Nationale Strategie gegen Krebs (NSK)
10.07.2017

MSD is “Top Employer Switzerland 2017” and “Top Employer Europe 2017”
24.05.2017

MSD reintegrates vaccines division into its portfolio
03.01.2017

Follow MSD Switzerland


CH-NON-00579, 05/2020